Quantcast

Latest Thrombolysis Stories

2011-03-03 13:35:00

RESEARCH TRIANGLE PARK, N.C., March 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by...

2011-02-21 08:11:56

(Ivanhoe Newswire) -- Whether or not you're a fan of Indian, Southeast Asian or Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center say you might become fond of one of their key spices. Curcumin is the principal curcuminoid of the popular Indian spice turmeric, which is a member of the ginger family.  Turmeric is currently being investigated for possible benefits in Alzheimer's disease, cancer, arthritis, and other clinical disorders as well. In the latter half...

2011-02-11 19:06:09

Rapid treatment associated with lower risk of death from acute stroke Every minute counts after the onset of a stroke. The more time that elapses before a patient receives an intravenous drug to help break up the clot that is blocking a blood vessel in the brain, the slimmer the chances of a good outcome. Less than one-third of acute stroke patients treated with the clot-busting drug, called intravenous tissue plasminogen activator (tPA), receive it within 60 minutes of their hospital...

2011-02-11 13:26:25

American Stroke Association meeting report Less than one-third of acute stroke patients treated with intravenous tissue plasminogen activator (tPA) receive the clot-busting drug within 60 minutes of their hospital arrival, according to research presented at the American Stroke Association's International Stroke Conference 2011. The research is simultaneously published in Circulation: Journal of the American Heart Association. The drug is a proven intervention for acute ischemic stroke...

2011-02-10 15:38:36

American Stroke Association meeting report Among patients who have had strokes but aren't sure when symptoms began, magnetic resonance imaging (MRI) can help distinguish who might benefit from clot-busting drugs while facing acceptable risk, according to research presented at the American Stroke Association's International Stroke Conference 2011. Researchers used MRI techniques to screen 430 patients with unclear-onset stroke at six university hospitals in South Korea. Strokes are categorized...

2011-02-10 12:14:39

Study from Cedars-Sinai Medical Center presented at American Heart Association International Stroke Conference Whether or not you're fond of Indian, Southeast Asian and Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center think you may become a fan of one of their key spices. The scientists created a new molecule from curcumin, a chemical component of the golden-colored spice turmeric, and found in laboratory experiments that it affects mechanisms that protect and help...

dae652811b276b8ed2cd60f15d98f452
2011-02-10 06:00:00

Hospitalization due to stroke rose significantly among Americans under the age of 45, particularly teenage boys and men under 34, between 1994 and 2007, according to a new study out on Wednesday. Researchers could not determine a cause for the increase in younger stroke victims, since the study only examined the number of hospitalizations, but do say the findings warrant further studies into obesity and high blood pressure. "I believe this is the first large study to report these findings,...

2011-02-09 13:53:52

Treating mild strokes with the clot-busting drug approved for severe stroke could reduce the number of patients left disabled and save $200 million a year in disability costs, according to new research from the University of Cincinnati (UC). The study led by Pooja Khatri, MD, an associate professor in the department of neurology, examined the public health impact of treating mild strokes with the clot-busting drug intravenous tissue plasminogen activator (tPA). It is being presented...

2011-02-09 13:52:32

American Stroke Association meeting report Treating mild strokes with the clot-busting drug approved for severe stroke could reduce the number of patients left disabled and save $200 million a year in disability costs, according to a study presented at the American Stroke Association's International Stroke Conference 2011. Researchers analyzed hospital records from 437 patients diagnosed with mild ischemic stroke at 16 sites in the Greater Cincinnati/Northern Kentucky region in 2005. The...

2011-02-09 13:49:00

The number of acute ischemic stroke hospitalizations among middle-aged and older men and women fell between 1994 and 2007, but sharply increased among those under age 35 "” including teens and children "” according to research presented at the American Stroke Association's International Stroke Conference 2011. Analysts at the U.S. Centers for Disease Control and Prevention (CDC), reviewing hospitalization data by age and gender, identified declining rates of 51 percent in girls...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.